228 related articles for article (PubMed ID: 16220917)
1. Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.
Helm JS; Hu Y; Chen L; Gross B; Walker S
J Am Chem Soc; 2003 Sep; 125(37):11168-9. PubMed ID: 16220917
[TBL] [Abstract][Full Text] [Related]
2. Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.
Hu Y; Helm JS; Chen L; Ginsberg C; Gross B; Kraybill B; Tiyanont K; Fang X; Wu T; Walker S
Chem Biol; 2004 May; 11(5):703-11. PubMed ID: 15157881
[TBL] [Abstract][Full Text] [Related]
3. Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurG.
Liu H; Ritter TK; Sadamoto R; Sears PS; Wu M; Wong CH
Chembiochem; 2003 Jul; 4(7):603-9. PubMed ID: 12851929
[TBL] [Abstract][Full Text] [Related]
4. E. Coli MurG: a paradigm for a superfamily of glycosyltransferases.
Ha S; Gross B; Walker S
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):201-13. PubMed ID: 12455415
[TBL] [Abstract][Full Text] [Related]
5. A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesis.
Barbosa MD; Ross HO; Hillman MC; Meade RP; Kurilla MG; Pompliano DL
Anal Biochem; 2002 Jul; 306(1):17-22. PubMed ID: 12069409
[TBL] [Abstract][Full Text] [Related]
6. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.
Branstrom AA; Midha S; Longley CB; Han K; Baizman ER; Axelrod HR
Anal Biochem; 2000 May; 280(2):315-9. PubMed ID: 10790316
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
8. Role of the amino acid invariants in the active site of MurG as evaluated by site-directed mutagenesis.
Crouvoisier M; Auger G; Blanot D; Mengin-Lecreulx D
Biochimie; 2007 Dec; 89(12):1498-508. PubMed ID: 17692452
[TBL] [Abstract][Full Text] [Related]
9. Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.
Mann PA; Müller A; Xiao L; Pereira PM; Yang C; Ho Lee S; Wang H; Trzeciak J; Schneeweis J; Dos Santos MM; Murgolo N; She X; Gill C; Balibar CJ; Labroli M; Su J; Flattery A; Sherborne B; Maier R; Tan CM; Black T; Onder K; Kargman S; Monsma FJ; Pinho MG; Schneider T; Roemer T
ACS Chem Biol; 2013 Nov; 8(11):2442-51. PubMed ID: 23957438
[TBL] [Abstract][Full Text] [Related]
10. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
[TBL] [Abstract][Full Text] [Related]
11. The essential peptidoglycan glycosyltransferase MurG forms a complex with proteins involved in lateral envelope growth as well as with proteins involved in cell division in Escherichia coli.
Mohammadi T; Karczmarek A; Crouvoisier M; Bouhss A; Mengin-Lecreulx D; den Blaauwen T
Mol Microbiol; 2007 Aug; 65(4):1106-21. PubMed ID: 17640276
[TBL] [Abstract][Full Text] [Related]
12. The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis.
Ha S; Walker D; Shi Y; Walker S
Protein Sci; 2000 Jun; 9(6):1045-52. PubMed ID: 10892798
[TBL] [Abstract][Full Text] [Related]
13. The biosynthesis of peptidoglycan lipid-linked intermediates.
Bouhss A; Trunkfield AE; Bugg TD; Mengin-Lecreulx D
FEMS Microbiol Rev; 2008 Mar; 32(2):208-33. PubMed ID: 18081839
[TBL] [Abstract][Full Text] [Related]
14. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention.
Zawadzke LE; Wu P; Cook L; Fan L; Casperson M; Kishnani M; Calambur D; Hofstead SJ; Padmanabha R
Anal Biochem; 2003 Mar; 314(2):243-52. PubMed ID: 12654311
[TBL] [Abstract][Full Text] [Related]
15. Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis.
Helm JS; Chen L; Walker S
J Am Chem Soc; 2002 Nov; 124(47):13970-1. PubMed ID: 12440876
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycosyltransferase activities as the basis for drug development.
Schutzbach J; Brockhausen I
Methods Mol Biol; 2009; 534():359-73. PubMed ID: 19277539
[TBL] [Abstract][Full Text] [Related]
17. The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis.
Laddomada F; Miyachiro MM; Jessop M; Patin D; Job V; Mengin-Lecreulx D; Le Roy A; Ebel C; Breyton C; Gutsche I; Dessen A
Sci Rep; 2019 Mar; 9(1):4656. PubMed ID: 30874582
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Pseudomonas aeruginosa MurG: UDP-GlcNAc substrate complex.
Brown K; Vial SC; Dedi N; Westcott J; Scally S; Bugg TD; Charlton PA; Cheetham GM
Protein Pept Lett; 2013 Sep; 20(9):1002-8. PubMed ID: 22973843
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor.
Derouaux A; Turk S; Olrichs NK; Gobec S; Breukink E; Amoroso A; Offant J; Bostock J; Mariner K; Chopra I; Vernet T; Zervosen A; Joris B; Frère JM; Nguyen-Distèche M; Terrak M
Biochem Pharmacol; 2011 May; 81(9):1098-105. PubMed ID: 21356201
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
